Intracellular activity of zidovudine (3'-azido-3'-deoxythymidine, AZT) against Salmonella typhimurium in the macrophage cell line J774-2
- 1 May 1992
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 36 (5), 1081-1085
- https://doi.org/10.1128/aac.36.5.1081
Abstract
The antibacterial effect of zidovudine (AZT) has been demonstrated both in vitro and in vivo with experimental models of gram-negative bacterial infections. It has been associated with the absence or low occurrence of nontyphoid Salmonella infections in AIDS patients treated with AZT. Using the macrophage cell line J774-2, we demonstrate the inhibition of intracellular growth of Salmonella typhimurium by AZT. This effect is obtained with one-half of the MIC (1 microgram/ml) of AZT for S. typhimurium. Inhibition of intracellular growth is observed after 4 h of incubation and persists at 24 h. Maximal inhibition is shown at a concentration of 128 micrograms/ml, and no further effect is observed with higher concentrations. When the inhibitory effect of AZT is compared with that of pefloxacin or that of ceftriaxone at half their MICs (0.2 and 0.02 microgram/ml, respectively), AZT and pefloxacin give better results than ceftriaxone. In this study, using an intracellular model, we show that AZT is able to inhibit the intracellular multiplication of S. typhimurium at a minimal effective concentration lower than the MIC, indicating its potential for antibacterial accumulation in the macrophages.Keywords
This publication has 17 references indexed in Scilit:
- Efficacy of Zidovudine in Preventing Relapses of Salmonella Bacteremia in AIDSThe Journal of Infectious Diseases, 1991
- Mechanisms of zidovudine resistance in bacteriaJournal of Medical Microbiology, 1990
- Isolation of zidovudine resistant Escherichia coli from AIDS patientsFEMS Microbiology Letters, 1990
- Zidovudine-resistance in Saimonella typhimurium and Escherichia coliJournal of Antimicrobial Chemotherapy, 1990
- Expression of host resistance to Salmonella typhi and Salmonella typhimurium: bacterial survival within macrophages of murine and human originMicrobial Pathogenesis, 1990
- Conditions required for the antibacterial activity of zidovudineEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- In vivo efficacy of zidovudine (3'-azido-3'-deoxythymidine) in experimental gram-negative-bacterial infectionsAntimicrobial Agents and Chemotherapy, 1989
- A Salmonella Locus that Controls Resistance to Microbicidal Proteins from Phagocytic CellsScience, 1989
- Salmonellosis During Infection with Human Immunodeficiency VirusClinical Infectious Diseases, 1987
- Antibacterial activity and mechanism of action of 3'-azido-3'-deoxythymidine (BW A509U)Antimicrobial Agents and Chemotherapy, 1987